Phocas Financial Corp. Nuvasive Inc Transaction History

Phocas Financial Corp.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$47.43 - $60.75 $2.87 Million - $3.68 Million	-60,531 Closed	0 $0
Q2 2020 Aug 24, 2020	BUY	$43.51 - $66.59 $731,011 - $1.12 Million	16,801 Added 38.42%	60,531 $3.37 Million
Q1 2020 May 15, 2020	SELL	$32.82 - $81.13 $1.89 Million - $4.67 Million	-57,541 Reduced 56.82%	43,730 $2.22 Million
Q4 2019 Feb 14, 2020	SELL	$60.96 - $77.7 $1.56 Million - $1.98 Million	-25,545 Reduced 20.14%	101,271 $7.83 Million
Q3 2019 Nov 15, 2019	SELL	$55.78 - $68.08 $9,594 - $11,709	-172 Reduced 0.14%	126,816 $8.04 Million
Q2 2019 Aug 16, 2019	BUY	$53.69 - $65.47 $1.66 Million - $2.03 Million	30,939 Added 32.21%	126,988 $0
Q1 2019 May 13, 2019	SELL	$44.53 - $58.9 $45,687 - $60,431	-1,026 Reduced 1.06%	96,049 $5.46 Million
Q4 2018 Feb 15, 2019	SELL	$47.64 - $71.26 $98,900 - $147,935	-2,076 Reduced 2.09%	97,075 $4.81 Million
Q3 2018 Nov 15, 2018	SELL	$52.03 - $71.41 $93,862 - $128,823	-1,804 Reduced 1.79%	99,151 $7.04 Million
Q2 2018 Aug 15, 2018	BUY	$48.15 - $56.68 $4.86 Million - $5.72 Million	100,955 New	100,955 $5.26 Million

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Phocas Financial Corp., based on Form 13F filings with the SEC.

Stay updated on Phocas Financial Corp. with notifications on news.